Patients with diabetes have a well-established elevated risk of cardiovascular disease. Statins reduce morbidity and mortality among patients with diabetes, but their use remains suboptimal. In this study, HIP Investigator Dr. Meghan Brennan et al. sought to understand trends in statin use to inform strategies for improvement. They found that Statin use is slowly increasing among patients with diabetes, and at varying rates within subgroups of this population. Policies that prioritize these subgroups for statin promotion may help guide future, intervention-based research to increase compliance with current guidelines.
Read the article